By Sneha S K May 31 (Reuters) - Johnson & Johnson's prostate cancer drug Erleada used with hormone-blocking therapy six ...

Results of a multicenter clinical trial found that adding the investigational adenoviral-based viral immunotherapy ...

By doing hormone therapy up front in prostate cancer cases, the hope was to shrink the relapse rate after surgery. Results ...

Doctors followed standard testing guidelines, which recommend discontinuing screenings for men over 70 years old. Should that ...

In prostate cancer, hormone therapy is treatment to keep the cancer cells from getting testosterone, the main male hormone (androgen). Hormone therapy for prostate cancer is also called ...

ADT plus apalutamide before and after surgery significantly improved metastasis-free survi ...

Radical prostatectomy is potentially curative in patients with high-risk localized or locally advanced prostate cancer; however, relapse occurs within 5 years in up to 50% of patients. We ...

Talazoparib plus enzalutamide reduces progression risk by 50% in men with DNA repair alter ...

A growing body of evidence suggests that popular GLP-1 drugs, widely used for weight loss and diabetes, can provide ...